uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted November 21, 2015

FTC Charges Maker of Supplement for Opiate Addiction with Deceptive Claims

On November 16, 2015, the FTC filed a lawsuit against Sunrise Nutraceuticals, LLC, charging that the company made deceptive claims its product, Elimidrol, can alleviate opiate withdrawal symptoms and increase a user's likelihood of overcoming opiate addiction. 

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at